Tenaya Therapeutics, Inc.
TNYA
$2.13
$0.115.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 3.87% | 8.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.55% | 11.71% | |||
| Operating Income | 12.55% | -11.71% | |||
| Income Before Tax | 13.33% | -12.70% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.33% | -12.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.33% | -12.70% | |||
| EBIT | 12.55% | -11.71% | |||
| EBITDA | 11.57% | -10.26% | |||
| EPS Basic | 41.51% | 11.38% | |||
| Normalized Basic EPS | 41.49% | 11.37% | |||
| EPS Diluted | 41.51% | 11.38% | |||
| Normalized Diluted EPS | 41.49% | 11.37% | |||
| Average Basic Shares Outstanding | 48.17% | 27.15% | |||
| Average Diluted Shares Outstanding | 48.17% | 27.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||